世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dermatophytic Onychomycosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1806
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身療法、局所療法、その他）、用途別市場規模（病院、皮膚科クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・皮膚糸状菌性爪真菌症治療（DOT）の市場動向
・企業の競争状況、市場シェア
・皮膚糸状菌性爪真菌症治療（DOT）の種類別市場規模（全身療法、局所療法、その他）
・皮膚糸状菌性爪真菌症治療（DOT）の用途別市場規模（病院、皮膚科クリニック、その他）
・皮膚糸状菌性爪真菌症治療（DOT）の北米市場規模2016-2027（アメリカ、カナダ）
・皮膚糸状菌性爪真菌症治療（DOT）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・皮膚糸状菌性爪真菌症治療（DOT）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・皮膚糸状菌性爪真菌症治療（DOT）の中南米市場規模2016-2027（メキシコ、ブラジル）
・皮膚糸状菌性爪真菌症治療（DOT）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bausch Health Companies、Novartis AG、Johnson and Johnson、Galderma S.A.、Celtic Pharmaceuticals、Anacor Pharmaceuticals、Moberg Pharma AB、GlaxoSmithKline、Pfizer Inc）
・結論

Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.
Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.

Market Analysis and Insights: Global Dermatophytic Onychomycosis Treatment Market
The global Dermatophytic Onychomycosis Treatment market size is projected to reach US$ 1879.3 million by 2026, from US$ 1148.8 million in 2019, at a CAGR of 7.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatophytic Onychomycosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatophytic Onychomycosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatophytic Onychomycosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatophytic Onychomycosis Treatment market.

Global Dermatophytic Onychomycosis Treatment Scope and Market Size
Dermatophytic Onychomycosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytic Onychomycosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Systemic Therapy
Topical Therapy
Other

Segment by Application
Hospitals
Dermatology Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health Companies
Novartis AG
Johnson and Johnson
Galderma S.A.
Celtic Pharmaceuticals
Anacor Pharmaceuticals
Moberg Pharma AB
GlaxoSmithKline
Pfizer Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Systemic Therapy
1.2.3 Topical Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dermatophytic Onychomycosis Treatment Market Perspective (2016-2027)
2.2 Dermatophytic Onychomycosis Treatment Growth Trends by Regions
2.2.1 Dermatophytic Onychomycosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatophytic Onychomycosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dermatophytic Onychomycosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dermatophytic Onychomycosis Treatment Industry Dynamic
2.3.1 Dermatophytic Onychomycosis Treatment Market Trends
2.3.2 Dermatophytic Onychomycosis Treatment Market Drivers
2.3.3 Dermatophytic Onychomycosis Treatment Market Challenges
2.3.4 Dermatophytic Onychomycosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue
3.1.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dermatophytic Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Treatment Revenue
3.4 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio
3.4.1 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Treatment Revenue in 2020
3.5 Dermatophytic Onychomycosis Treatment Key Players Head office and Area Served
3.6 Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
3.7 Date of Enter into Dermatophytic Onychomycosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatophytic Onychomycosis Treatment Breakdown Data by Type
4.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2022-2027)

5 Dermatophytic Onychomycosis Treatment Breakdown Data by Application
5.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
6.2 North America Dermatophytic Onychomycosis Treatment Market Size by Type
6.2.1 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
6.3 North America Dermatophytic Onychomycosis Treatment Market Size by Application
6.3.1 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
6.4 North America Dermatophytic Onychomycosis Treatment Market Size by Country
6.4.1 North America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
7.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Type
7.2.1 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
7.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Application
7.3.1 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
7.4 Europe Dermatophytic Onychomycosis Treatment Market Size by Country
7.4.1 Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type
8.2.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application
8.3.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region
8.4.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
9.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type
9.2.1 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application
9.3.1 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country
9.4.1 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type
10.2.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application
10.3.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country
10.4.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Details
11.1.2 Bausch Health Companies Business Overview
11.1.3 Bausch Health Companies Dermatophytic Onychomycosis Treatment Introduction
11.1.4 Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.1.5 Bausch Health Companies Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Dermatophytic Onychomycosis Treatment Introduction
11.2.4 Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Dermatophytic Onychomycosis Treatment Introduction
11.3.4 Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.3.5 Johnson and Johnson Recent Development
11.4 Galderma S.A.
11.4.1 Galderma S.A. Company Details
11.4.2 Galderma S.A. Business Overview
11.4.3 Galderma S.A. Dermatophytic Onychomycosis Treatment Introduction
11.4.4 Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.4.5 Galderma S.A. Recent Development
11.5 Celtic Pharmaceuticals
11.5.1 Celtic Pharmaceuticals Company Details
11.5.2 Celtic Pharmaceuticals Business Overview
11.5.3 Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
11.5.4 Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.5.5 Celtic Pharmaceuticals Recent Development
11.6 Anacor Pharmaceuticals
11.6.1 Anacor Pharmaceuticals Company Details
11.6.2 Anacor Pharmaceuticals Business Overview
11.6.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
11.6.4 Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.6.5 Anacor Pharmaceuticals Recent Development
11.7 Moberg Pharma AB
11.7.1 Moberg Pharma AB Company Details
11.7.2 Moberg Pharma AB Business Overview
11.7.3 Moberg Pharma AB Dermatophytic Onychomycosis Treatment Introduction
11.7.4 Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.7.5 Moberg Pharma AB Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Dermatophytic Onychomycosis Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Pfizer Inc
11.9.1 Pfizer Inc Company Details
11.9.2 Pfizer Inc Business Overview
11.9.3 Pfizer Inc Dermatophytic Onychomycosis Treatment Introduction
11.9.4 Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
11.9.5 Pfizer Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Systemic Therapy
Table 3. Key Players of Topical Therapy
Table 4. Key Players of Other
Table 5. Global Dermatophytic Onychomycosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dermatophytic Onychomycosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dermatophytic Onychomycosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2016-2021)
Table 9. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2022-2027)
Table 11. Dermatophytic Onychomycosis Treatment Market Trends
Table 12. Dermatophytic Onychomycosis Treatment Market Drivers
Table 13. Dermatophytic Onychomycosis Treatment Market Challenges
Table 14. Dermatophytic Onychomycosis Treatment Market Restraints
Table 15. Global Dermatophytic Onychomycosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dermatophytic Onychomycosis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2020)
Table 18. Ranking of Global Top Dermatophytic Onychomycosis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dermatophytic Onychomycosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
Table 22. Date of Enter into Dermatophytic Onychomycosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dermatophytic Onychomycosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bausch Health Companies Company Details
Table 63. Bausch Health Companies Business Overview
Table 64. Bausch Health Companies Dermatophytic Onychomycosis Treatment Product
Table 65. Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 66. Bausch Health Companies Recent Development
Table 67. Novartis AG Company Details
Table 68. Novartis AG Business Overview
Table 69. Novartis AG Dermatophytic Onychomycosis Treatment Product
Table 70. Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis AG Recent Development
Table 72. Johnson and Johnson Company Details
Table 73. Johnson and Johnson Business Overview
Table 74. Johnson and Johnson Dermatophytic Onychomycosis Treatment Product
Table 75. Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 76. Johnson and Johnson Recent Development
Table 77. Galderma S.A. Company Details
Table 78. Galderma S.A. Business Overview
Table 79. Galderma S.A. Dermatophytic Onychomycosis Treatment Product
Table 80. Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 81. Galderma S.A. Recent Development
Table 82. Celtic Pharmaceuticals Company Details
Table 83. Celtic Pharmaceuticals Business Overview
Table 84. Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Product
Table 85. Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 86. Celtic Pharmaceuticals Recent Development
Table 87. Anacor Pharmaceuticals Company Details
Table 88. Anacor Pharmaceuticals Business Overview
Table 89. Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Product
Table 90. Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 91. Anacor Pharmaceuticals Recent Development
Table 92. Moberg Pharma AB Company Details
Table 93. Moberg Pharma AB Business Overview
Table 94. Moberg Pharma AB Dermatophytic Onychomycosis Treatment Product
Table 95. Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 96. Moberg Pharma AB Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Pfizer Inc Company Details
Table 102. Pfizer Inc Business Overview
Table 103. Pfizer Inc Dermatophytic Onychomycosis Treatment Product
Table 104. Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
Table 105. Pfizer Inc Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytic Onychomycosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Systemic Therapy Features
Figure 3. Topical Therapy Features
Figure 4. Other Features
Figure 5. Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Dermatology Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Dermatophytic Onychomycosis Treatment Report Years Considered
Figure 10. Global Dermatophytic Onychomycosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Dermatophytic Onychomycosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dermatophytic Onychomycosis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Dermatophytic Onychomycosis Treatment Market Share by Players in 2020
Figure 15. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Treatment Revenue in 2020
Figure 17. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
Figure 21. North America Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
Figure 22. North America Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
Figure 23. United States Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Region (2016-2027)
Figure 39. China Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bausch Health Companies Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 59. Novartis AG Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 60. Johnson and Johnson Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 61. Galderma S.A. Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 62. Celtic Pharmaceuticals Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 63. Anacor Pharmaceuticals Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 64. Moberg Pharma AB Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 66. Pfizer Inc Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size, Status and Forecast 2021-2027
QYR2104Z1805 2021年4月 98Pages
QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口療法）、用途別市場規模（病院、皮膚科・足病クリニック、独立薬局、通信販売薬局、ドラッグストア）、主要地域別市...

世界の皮膚糸状菌性爪真菌症（DO）市場規模・現状・予測（2021年-2027年）

Global Dermatophytic Onychomycosis Market Size, Status and Forecast 2021-2027
QYR2104Z1804 2021年4月 99Pages
QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症（DO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（18歳以下、18〜50歳、50歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の爪真菌症市場規模・現状・予測（2021年-2027年）

Global Onychomycosis Market Size, Status and Forecast 2021-2027
QYR2104Z4267 2021年4月 95Pages
QYResearch社発行の本調査資料では、爪真菌症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遠位爪下爪真菌症、白色表在性爪真菌症、近位爪下爪真菌症、カンジダ爪真菌症、その他）、用途別市場規模（病院薬局、ドラッグストア、その他）、主要地域...

世界の爪真菌症市場規模・現状・予測（2021年-2027年）

世界の多形性膠芽腫治療（GBM）市場規模・現状・予測（2021年-2027年）

Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2021-2027
QYR2104Z2585 2021年4月 95Pages
QYResearch社発行の本調査資料では、多形性膠芽腫治療（GBM）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）、用途別市場規模（病院・クリニック、ASC、その他）、主要地域別市場...

世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年）

Global Diabetic Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1836 2021年4月 92Pages
QYResearch社発行の本調査資料では、糖尿病性ニューロパチー治療（DN）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経障害、自律神経障害、近位神経障害、限局性神経障害）、用途別市場規模（病院、クリニック、薬局）、主要地域別市場規...

世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年）

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5010 2021年4月 93Pages
QYResearch社発行の本調査資料では、気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

世界の疥癬治療市場規模・現状・予測（2021年-2027年）

Global Scabies Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5120 2021年4月 98Pages
QYResearch社発行の本調査資料では、疥癬治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（軟膏、併用薬、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…
世界の皮膚糸状菌性爪真菌症（DO）市場規模・現状・予測（2021年-2027年） Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes…
世界の爪真菌症市場規模・現状・予測（2021年-2027年） Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Co…
世界の爪真菌症市場規模・現状・予測（2021年-2027年） Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Co…
世界の全身感染療法市場規模・現状・予測（2021年-2027年） Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the person’s bloodstream and gradually spreads to the whole body. The systemic infections can range from common ones such as flu, …